Impact Factor
3.19
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.25
276 total citations
h5-index
28
h5 depth signal
Cited share
73.2%
101 of 138
Total citations
276
Citation footprint
Metric signal
2.14
External metric anchor
Self-citation
1.8%
5 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
237
United States
116
Iran
97
India
97
Brazil
95
Citing Fields of Research
Antibiotic & Antibacterial Agents
1,212
Bacteriology
571
Mycobacterial Diseases
66
Fungal Pathogenesis
26
Sexually Transmitted Diseases
24
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,639
Articles tracked across the journal lifetime
Indexed publication set
138
101 cited publications
Last 12 months
89
7.4 publications/month
Open access share
2.2%
2 OA publications in the last year
Leading citing country
China
237 citing publications
Leading citing field
Antibiotic & Antibacterial Agents
1,212 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v3n1,spring 1997-
v3n1,spring 1997-
Active Coverage
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Bacteriology
Broad Categories
Anti-Infective Agents
Microbiology
Antibiotic & Antibacterial Agents
MeSH Descriptors
Drug Resistance, Microbial
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/10766294261500213
Open DOI
The Potential Role of Gut Microbiota in Combating Mycobacterium tuberculosis Infection
Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis ( M.TB ) infection. Although there have been significant advances in the treatment of M.TB infection, it still faces significant challenges. The gut m...
02
DOI 10.1177/10766294261489643
Open DOI
Prevalence of Fosfomycin-Resistant Escherichia coli from Livestock, Companion Animals, and the Environment in Japan, and Genomic Characterization of Transferable fos Genes
Fosfomycin is a highest priority critically important antimicrobial in medical settings and is approved for use in cattle, fish, and humans in Japan. Breakpoints for fosfomycin differ between the antimicrobial susceptibility test guideli...
03
DOI 10.1177/10766294261489647
Open DOI
Risk Factors for Extended-Spectrum β-lactamase, Carbapenem, and Colistin Resistance Among Enterobacterales Bloodstream Infections in Intensive Care Units
Enterobacterales bloodstream infections (E-BSIs) in intensive care units (ICUs) are increasingly complicated by antimicrobial resistance. This retrospective study evaluated resistance patterns and phenotype-specific risk factors for exte...
04
DOI 10.1177/10766294261487476
Open DOI
Emerging of bla NDM-5 in Providencia rettgeri and Morganella morganii from Brazilian Clinical Isolates
The genus Providencia and Morganella are part of the World Health Organization (WHO) critical priority pathogens when carbapenem-resistant. This study characterized the molecular epidemiology of carbapenemase genes in 13 clinical isolate...
05
DOI 10.1177/10766294261484662
Open DOI
12-Year Experience with Rapid PCR for Carbapenemase-Producing Enterobacteriaceae Screening in a Public Hospital in France
France issued recommendations to control the spread of carbapenemase-producing Enterobacteriaceae (CPE) in 2013. We describe our experience with the implementation of national CPE screening guidelines in a French public hospital and its ...
06
DOI 10.1177/10766294261484663
Open DOI
The Conjugative Megaplasmid pMD9A Mediates Transferring Antibiotic Resistance Genes
Pseudomonas asiaticais an emerging opportunistic pathogen with a broad host range. Current evidence suggests that some isolates exhibit multidrug resistance, which may complicate treatment. In this study, a multidrug-resistant P. asiatic...
07
DOI 10.1177/10766294261485031
Open DOI
Using an Online Registry of Carbapenemase-Producing Gram-Negative Organisms to Report the Clinical Profile, Outcomes, and Phenotypic and Genotypic Resistances in Two Tertiary Level Hospitals in the Philippines (ORiGiN Study)
Background: This study describes the clinical profiles, phenotypic and genotypic resistance mechanisms, and outcomes of patients with carbapenem-resistant infections (CRIs) using a registry. Methods: Hospitalized adults with CRIs in two ...
08
DOI 10.1177/10766294261480779
Open DOI
High-Risk Clones of Carbapenem-Resistant Pseudomonas aeruginosa in India: Genome and Traits
Pseudomonas aeruginosa is a notorious opportunistic pathogen constituting a major cause of health care-associated infections worldwide. Intrinsic resistance to multiple antibiotics, with acquired resistance mechanisms and hypervirulence ...
09
DOI 10.1177/10766294261480769
Open DOI
Carbapenem-Resistant Gram-Negative Bacilli in China: Current Situation and Trend Inference (2014–2029)
The objective of this study was to analyze longitudinal trends in the detection rates of Carbapenem-resistant Gram-negative bacilli (CRGNB) in China from 2014 to 2024, and to forecast their evolution over the subsequent five years. Surve...
10
DOI 10.1177/10766294261478179
Open DOI
Prevalence and Molecular Characterization of Aminoglycoside Resistance Genes Among Drug-Resistant Pseudomonas aeruginosa Clinical Isolates in Chinese Hospital
Background: Pseudomonas aeruginosa is a major cause of nosocomial infections, with increasing multidrug resistance complicating treatment outcomes. Aminoglycosides remain a cornerstone for managing P. aeruginosa infections, but resistanc...
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Vol. 1, no. 1 (SPRING 1995)19970106 Notice published Printed on acid-free paper